All Blog Posts
Topics
International Men’s Health Week
June 18, 2021
During the second week of June, between June 14 – 20, 2021, International Men’s Health Week is celebrated globally. The week is about raising awareness for the importance of health and wellness for boys and men all over the world. To honor this week, we wanted to put the question to two of our employees at Atlas Antibodies and ask them a little bit about their views on health and how they see the importance of maintaining good health in their individual lives. Read on to hear from Jonatan and Jonathan on how important good health is to them.
-
Distributor Spotlight - LubioScience
June 14, 2021At Atlas Antibodies we expand our offering through our trusted partner network, and in our distributor Spotlight series we wanted to shed some extra light on this great network of ours starting with one of our distributors LubioScience. Read on to discover the story of this life science company based in Switzerland. -
TopicsResearch roundup: diagnostic and prognostic cancer markers
June 03, 2021Interested in seeing more of our cancer research antibodies in action? The following three studies have all successfully utilized different Atlas Antibodies products to suggest or identify new biomarkers for different cancers. -
Research roundup: see our neuroscience products in action
Our antibodies are used in cutting-edge neuroscience research around the world. All our neuroscience products are highly validated and created using a unique antigen design for optimal specificity, affinity-purified using the immunogen, and manufactured using a standardized production process to ensure the highest quality. Let's take a look at three recent studies showing our neuroscience products in action. -
TopicsEmployee Spotlight
For our employee spotlight series, it is now time to put the spotlight on one member of our brilliant team to get to know her a little bit better. Meet Christine Hemming, our excellent Group Leader in quality control (QC). Read below to find out more about her and her career path. -
Interview with a scientist: proteomics, biomarkers and ALS.
March 30, 2021No effective therapies are currently available for Amyotrophic Lateral Sclerosis due to the lack of biomarkers for early diagnosis and monitoring disease progression. Meet here, Dr. Valentina Bonetto, and read about her research efforts based on proteomic assays to find validated biomarkers and innovative therapeutic strategies -
TopicsCelebrating International Women’s Day
March 08, 2021Every year on March 8th, we observe International Women’s day to celebrate women’s achievements throughout history and advocate for increased gender equality worldwide. Hear from two women at Atlas Antibodies about their careers and advice that they would give other women and girls interested in working in life sciences! -
Research roundup: neuroscience antibodies and protein standards
March 01, 2021Our highly-validated antibodies and QPrEST protein standards are used in cutting-edge neuroscience research. Read a roundup of some newly published studies to see our neuroscience antibodies and targeted proteomics in action! -
Topics
“I’ve had the privilege of taking inspiration from successful and inspiring women”: celebrating the day of women and girls in science.
February 11, 2021Today is the International Day of Women and Girls in Science 2021. We spoke to some female Atlas Antibodies employees about their roles, experiences, and what advice they would give to young people considering a career in life sciences. -
4 things I missed during the Society for Neuroscience virtual conference…or did I?
January 26, 2021The Society for Neuroscience, SfN, holds an annual meeting that is attended by scientists and physicians from all around the world. This year, because of the ongoing pandemic, the meeting was run virtually. Did I enjoy it? -
Topics
Research Roundup: prognostic biomarkers in cancer
January 21, 2021Many of our cancer antibodies are used in cutting-edge research to identify new prognostic markers in different cancers. Let's take a look at three recent studies.
